期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
Age-related increase of early afterdepolarization in calsequestrin-2 knock-in mouse cardiomycyte 被引量:1
1
作者 Yun-Feng Lan Yi Wen +8 位作者 Zhou Fang Jin-Lao Gao Yan Liu Men Lin Hong-Juan Wang Yi-Cheng Fu Prori S.G Carlo. Napolitano C Yang Li 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2010年第3期171-175,共5页
Objective To characterize early afterdepolarizations (EADs) caused triggered activity (TA) among calsequestrin-2 (CASQ2) knock-in (CASQ2 KI) mice and its relationship with aging. Methods Electrophysiological p... Objective To characterize early afterdepolarizations (EADs) caused triggered activity (TA) among calsequestrin-2 (CASQ2) knock-in (CASQ2 KI) mice and its relationship with aging. Methods Electrophysiological properties of ventricular myocytes from 3- month (mo, young), 9-mo (adult-l) and 12-too (adult-2) in wild-type (WT) and CASQ2 KI mice were investigated with patch-clamp technique. Results The incidences of EADs and TA in CASQ2 KI cardiomyocytes increased with increasing age. In contrast, WT mice cardiomyocytes showed no significant change in matched-age groups. Compared with that in 3-mo CASQ2 KI mice, the 50% repolarization of action potential (APD50) showed prolongation in both 9-mo and 12-mo ones (9.2±0.9 ms of 9-mo and 10.3 ± 1.2 ms of 12- mo vs. 5.6± 0.3 ms of 3-mo), while the 90 % repolarization of action potential (APD90) was similar among 3 age groups. Compared with 3-mo mice, the 9-mo and 12-mo CASQ2 KI mice showed markedly reduced transient outward potassium current (Ito) densities but increased L-type calcium current (ICa-L) densities. Conlcusion This study suggested that events of EADs and TA in CASQ2 KI mice increased with increasing age, It might be associated partly with the augment of cellular calcium concentration and the prolongation of APD50 induced by decrease of Ito and increase of ICa-L in adult CASQ2 KI mice 展开更多
关键词 calsequestrin early afterdepolarization triggered activity gene mutation transgenic mice
下载PDF
Reduced expression of Ca^(2+)-regulating proteins in the upper gastrointestinal tract of patients with achalasia 被引量:1
2
作者 Harald Fischer Judith Fischer +5 位作者 Peter Boknik Ulrich Gergs Wilhelm Schmitz Wolfram Domschke Jan W Konturek Joachim Neumann 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第37期6002-6007,共6页
AIM: To compare expression of Ca2+-regulating proteins in upper gastrointestinal (GI) tract of achalasia patients and healthy volunteers and to elucidate their role in achalasia. METHODS: Sarcoplasmic reticulum Ca2+ A... AIM: To compare expression of Ca2+-regulating proteins in upper gastrointestinal (GI) tract of achalasia patients and healthy volunteers and to elucidate their role in achalasia. METHODS: Sarcoplasmic reticulum Ca2+ ATPase (SERCA) isoforms 2a and 2b, phospholamban (PLB), calsequestrin (CSQ), and calreticulin (CRT) were assessed by quantitative Western blotting in esophagus and heart of rats, rabbits, and humans. Furthermore, expression profi les of these proteins in biopsies of lower esophageal sphincter and esophagus from patients with achalasia and healthy volunteers were analyzed. RESULTS: SERCA 2a protein expression was much higher in human heart (cardiac ventricle) compared to esophagus. However, SERCA 2b was expressed predominantly in the esophagus. The highest CRT expression was noted in the human esophagus, while PLB, although highly expressed in the heart, was below our detection limit in upper GI tissue. Compared to healthy controls, CSQ and CRT expression in lower esophageal sphincter and distal esophageal body were signif icantly reduced in patients with achalasia (P < 0.05). CONCLUSION: PLB in the human esophagus mightbe of lesser importance for regulation of SERCA than in heart. Lower expression of Ca2+ storage proteins (CSQ and CRT) might contribute to increased lower esophageal sphincter pressure in achalasia, possibly by increasing free intracellular Ca2+. 展开更多
关键词 Esophageal and gastric motility ESOPHAGUS calsequestrin CALRETICULIN
下载PDF
Evidence, hypotheses and significance of MAP kinase TNNI3K interacting with its partners 被引量:1
3
作者 Zhong-Fang Lai Yu-Zhen Chen 《World Journal of Hypertension》 2012年第2期22-28,共7页
TNNI3K is a cardiac-specific and cardiac troponin I(cT n I)-interacting MAP kinase, known to play important roles in promoting cardiac differentiation, maintenance of beating rhythm and contractual force. The molecula... TNNI3K is a cardiac-specific and cardiac troponin I(cT n I)-interacting MAP kinase, known to play important roles in promoting cardiac differentiation, maintenance of beating rhythm and contractual force. The molecular structure of TNNI3 K contains three kinds of domain: a seven or ten NH2-terminal ankyrin repeat domain followed by a protein kinase domain and a COOH-terminal serine-rich domain. There are many binding sites in the structure of TNNI3 K for binding to ATP, magnesium, nucleotide, protein kinase C, antioxidant protein 1(AOP-1) and cT n I, indicating TNNI3 K has many interacting partners. This review summarizes the evidence, hypothesis and significance of TNNI3 K interacting with TNNI3 and its other putative interaction partners. From the literature, the interaction partners of TNNI3 K are divided into 2 types following their phenotypic pattern of functions, positive interaction(to increase the cardiac performance) or negative interaction(to suppress the cardiac performance). Following their binding sites, it also can be divided into other 2 types: binding to C-terminal domain(e.g., cT n I) or binding to both ankyrin repeat domain and C-terminal domains(AOP-1).To date, a well understood partner of TNNI3 K is cT nI, from the molecular structure, physiological function, mechanisms and its significance in some physiological and pathophysiological conditions. There are many reasons to believe that, with more understanding on the TNNI3 K interacting with its partners, we can understand more roles of TNNI3 K in some cardiac diseases. 展开更多
关键词 TNNI3K TNNI3 Cardiac-specific MAP kinase Velocity of DIASTOLIC depolarization Phosphorylation of cTnI Antioxidant PROTEIN 1 calsequestrin CARDIAC hypertrophy ENDOTHELIN-1 CARDIAC myosin binding PROTEIN C
下载PDF
慢性心衰大鼠心肌细胞内雷尼丁受体及集钙蛋白的表达
4
作者 胡淑婷 沈亚峰 +1 位作者 彭涛 杨勇骥 《解剖学杂志》 CAS CSCD 北大核心 2016年第5期529-533,共5页
目的: 研究慢性心衰大鼠心肌细胞内雷尼丁受体(RyR2)及其调节蛋白集钙蛋白的表达,探讨心衰心肌细胞内钙容量降低的机制.方法: 雄性SD大鼠被随机分为心衰组和假手术组,运用激光扫描共聚焦显微镜、透射电子显微镜、免疫印迹等方法研究... 目的: 研究慢性心衰大鼠心肌细胞内雷尼丁受体(RyR2)及其调节蛋白集钙蛋白的表达,探讨心衰心肌细胞内钙容量降低的机制.方法: 雄性SD大鼠被随机分为心衰组和假手术组,运用激光扫描共聚焦显微镜、透射电子显微镜、免疫印迹等方法研究2组大鼠心肌细胞肌浆网内钙容量、心肌细胞超微结构及心肌细胞内肌浆网钙释放通道RyR2和其调节蛋白集钙蛋白表达的变化.结果: 慢性心衰大鼠心功能左心室舒张末期压力、左室压力最大上升速率均显著低于假手术组.假手术组大鼠心肌细胞的肌小节完整,肌丝排列整齐,线粒体结构正常;心衰组大鼠部分心肌细胞肌丝溶解,线粒体肿胀,嵴断裂.慢性心衰大鼠心肌细胞肌浆网内钙容量显著低于假手术组.慢性心衰大鼠心肌细胞内RyR2的表达量无明显变化,集钙蛋白表达明显下降.结论: 慢性心衰大鼠心肌细胞内集钙蛋白表达下调,可能是导致心肌细胞肌浆网钙容量减少的原因之一. 展开更多
关键词 心力衰竭 心肌细胞 肌浆网 雷尼丁受体 集钙蛋白 大鼠
下载PDF
内毒素对大鼠心肌肌质网功能的抑制作用 被引量:1
5
作者 陈怀生 刘雪燕 +3 位作者 郭晓静 洪澄英 李威 曹静 《解放军医学杂志》 CAS CSCD 北大核心 2020年第7期697-701,共5页
目的观察内毒素致大鼠心肌肌质网相关酶学变化,评价内毒素对大鼠心肌肌质网功能的抑制作用。方法雄性SD大鼠10只,随机均分为空白对照组与内毒素注射组。内毒素注射组构建脓毒症大鼠模型,即从大鼠尾静脉注射脂多糖(0.7 mg/kg),1次/d,共2 ... 目的观察内毒素致大鼠心肌肌质网相关酶学变化,评价内毒素对大鼠心肌肌质网功能的抑制作用。方法雄性SD大鼠10只,随机均分为空白对照组与内毒素注射组。内毒素注射组构建脓毒症大鼠模型,即从大鼠尾静脉注射脂多糖(0.7 mg/kg),1次/d,共2 d。检测两组大鼠血流动力学参数,评价心肌组织的病理形态学变化,测定心室肌细胞肌质网钙调节蛋白mRNA的表达水平。结果与空白对照组比较,内毒素注射组大鼠心率增快[首日(204±18)次/min vs.(139±10)次/min,次日(199±22)次/min vs.(143±17)次/min,P<0.05],首日平均动脉压(MAP)降低[(87±12)mmHg vs.(102±7)mmHg,P<0.05]。光学显微镜及电子显微镜下可见,内毒素注射组大鼠心肌细胞排列疏松,细胞间炎性细胞浸润,肌纤维断裂,线粒体、肌质网形态辨认困难。反转录实时定量PCR(PT-qPCR)结果显示,注射内毒素后大鼠心室肌肌钙集蛋白(CASQ1)、钠-钙交换体(NCX)、钙调蛋白磷酸酶1(ppplCa)、受磷蛋白(PLN)、肌质网Ca^2+-ATP酶(SERCA2)mRNA表达水平均明显增加(P<0.05)。结论内毒素可通过多种机制影响肌质网钙调节蛋白的作用,抑制心肌细胞功能。 展开更多
关键词 内毒素 心肌细胞 肌质网Ca^2+-ATP酶 肌钙集蛋白 钠-钙交换体
下载PDF
集钙蛋白1相关肌病患者1例的基因变异分析
6
作者 郭璇 赵哲 +3 位作者 沈宏锐 邴琪 谢诗 胡静 《中华医学遗传学杂志》 CAS CSCD 2024年第6期745-748,共4页
目的:对1例骨骼肌活检以空泡及类似管聚集现象为特征性表现的肌病患者进行基因变异分析,明确其遗传学病因。方法:以。年。月。日就诊于河北医科大学第三医院的1例肌病患者作为研究对象。对患者进行高通量测序,并通过Sanger测序对结果进... 目的:对1例骨骼肌活检以空泡及类似管聚集现象为特征性表现的肌病患者进行基因变异分析,明确其遗传学病因。方法:以。年。月。日就诊于河北医科大学第三医院的1例肌病患者作为研究对象。对患者进行高通量测序,并通过Sanger测序对结果进行验证。结果:高通量测序显示患者集钙蛋白-1(calsequestrin-1,CASQ1)基因存在c.730G>C(p.D244H)杂合变异,其父母均未携带相同的变异。根据美国医学遗传学与基因组学学会相关指南,判定该变异为致病性(PS1+PM2+PP3)。结论:CASQ1基因c.730G>C(p.D244H)杂合错义变异可能是本研究患者的遗传学病因,新变异的检出丰富了CASQ1基因的变异谱。 展开更多
关键词 空泡性肌病 管聚集 CASQ1基因 运动不耐受 高肌酸激酶血症
原文传递
芪参益气滴丸对射血分数保留型心力衰竭小鼠的治疗作用
7
作者 张珍珍 王梦瑶 +5 位作者 韩延璐 胡蕴慧 李晓强 郭凯敏 段亚君 张爽 《药学学报》 CAS CSCD 北大核心 2024年第11期3094-3103,共10页
射血分数保留型心力衰竭(heart failure with preserved ejection fraction,HFpEF)约占心衰患者的一半数量,其特征除了心衰的典型特征如心肌僵硬、心脏舒张功能损伤等,最主要的特征是左心室射血正常,因此也给HFpEF的临床诊断增加了难度... 射血分数保留型心力衰竭(heart failure with preserved ejection fraction,HFpEF)约占心衰患者的一半数量,其特征除了心衰的典型特征如心肌僵硬、心脏舒张功能损伤等,最主要的特征是左心室射血正常,因此也给HFpEF的临床诊断增加了难度。芪参益气滴丸(QiShenYiQi Dripping Pills,QSYQ)是经中国食品药品监督管理局(CFDA)批准的标准化中药制剂,许多基础及临床研究均已证明QSYQ在治疗射血分数降低型心力衰竭中的有效性和安全性,然而QSYQ在HFpEF中的作用机制尚未明确。本文利用经典造模方法即高脂食物(high fat diet,HFD)和含N-硝基-L-精氨酸甲酯盐酸盐(L-NAME,0.5 g·L^(-1),pH=7.4)的饮用水喂食C57BL/6N雄性小鼠构建HFpEF模型(实验获得合肥工业大学动物伦理委员会批准,批准号为HFUT20220921002),在第8周,小鼠分别给药:(1)恩格列净(empagliflozin)、(2)低剂量QSYQ(LQ)、(3)高剂量QSYQ(HQ)、(4)恩格列净联用低剂量QSYQ(ELQ),连续给药4周,实验过程中记录小鼠的体重,实验结束后对小鼠进行超声心动检测、血压检测、葡萄糖耐量检测及评估小鼠运动情况,利用病理实验和生化实验检测小鼠心脏纤维化、肝脏纤维化及血清生化指标等,利用RNAseq测序对小鼠心脏进行RNAseq检测。结果表明,QSYQ及联用恩格列净均能够显著降低HFpEF小鼠体重,改善小鼠心脏舒张功能障碍和高血压,改善葡萄糖耐量异常并增强小鼠运动能力。在生化和分子水平上,QSYQ能够降低心肌细胞横截面积和减少心脏胶原蛋白含量进而减轻心肌肥大和纤维化表型,同时改善HFpEF小鼠机体脂质代谢紊乱。进一步地,小鼠心脏RNAseq结果表明,QSYQ改善HFpEF的功能可能与调控肌钙集蛋白1(calsequestrin 1,Casq1)有关。综上,本研究表明QSYQ能够显著改善HFpEF相关的心脏功能障碍和代谢紊乱,为HFpEF的临床治疗提供了一定实验数据支持。 展开更多
关键词 射血分数保留型心力衰竭 芪参益气滴丸 恩格列净 转录组测序 肌钙集蛋白1
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部